Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication201220132014201520162017201820192020202120222023202420252026 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyProduct Development Unit Oct 2025 Emerg Infect Dis Seoul Virus Infection Acquired at Private Pet Rat Breeding Facility, Germany, 2024 Autoren Baalmann F et al. Oct 2025 Clin Microbiol Rev Twenty years of human bocavirus research: from an unculturable virus of unclear pathogenicity to a culturable human pathogen and gene therapy vector candidate Autoren Schildgen O et al. Sep 2025 Adv Sci (Weinh) Cellular Hallmarks From Volume Electron Microscopy Reveal Developmental Progression of Plasmodium Ookinetes Autoren Darif N et al. Sep 2025 Am J Trop Med Hyg Clinical and Parasitological Characteristics of Plasmodium vivax Malaria in Malaria-Naïve Patients: A Review of Malaria Fever Therapy in Patients with Schizophrenia and Neurosyphilis during the 1950s and 1960s in Vienna, Austria Autoren Wolff S et al. Sep 2025 Antimicrob Agents Chemother Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant Candida parapsilosis bloodstream infections Autoren Vena A et al. Sep 2025 Am J Trop Med Hyg IgM, IgG, and IgG Subclass Antibody Responses to Plasmodium falciparum Proteins in Naïve, Malaria-Vaccinated and Semi-Immune Volunteers after Controlled Human Malaria Infection Autoren Gómez-Pérez GP et al. Sep 2025 Malar J Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridine Autoren Mombo-Ngoma G et al. Sep 2025 Sci Rep T cell dysregulation reflects disease stage in hepatitis virus and alcohol-related liver disease Autoren Niehaus C et al. Sep 2025 EMBO Mol Med Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil Autoren Borrmann S et al. Sep 2025 BMC Cancer Reviewing the lines of therapy-concept in cancer treatment: a survey study among physicians Autoren Falchetto LMM et al. Sep 2025 JAC Antimicrob Resist The 2025 EQUAL Pneumocystis Score-an ECMM tool to measure QUALity in Pneumocystis pneumonia management Autoren Haensel L et al. Sep 2025 Med Microbiol Immunol Effect of controlled human Plasmodium falciparum infection on B cell subsets in individuals with different levels of malaria immunity Autoren Requena P et al. Sep 2025 Infect Dis Poverty An exploratory study to assess the influence of schistosomiasis on the occurrence of dengue virus in Madagascar Autoren Hey JC et al. Sep 2025 Epidemiol Infect Evidence of very low hepatitis B virus prevalence in children and adolescents in Germany: National cross-sectional study, 2014-2017 Autoren Gillesberg Lassen S et al. Sep 2025 Nucleic Acids Res MITE: the Minimum Information about a Tailoring Enzyme database for capturing specialized metabolite biosynthesis Autoren Rutz A et al. Sep 2025 Eur J Health Econ Do we need a health technology assessment approach for non-inferiority specifically? A comment on: clinical equivalence and non-inferiority within health technology assessment by Taylor et al. (2025) Autoren Gladstone BP Vach W Sep 2025 Proc Natl Acad Sci U S A Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development Autoren Reuber EE et al. Sep 2025 Front Immunol Helminthic larval stage induces cellular apoptosis via caspase 9-mediated mitochondrial dysfunction Autoren Sternkopf LE et al. Sep 2025 Trop Med Int Health Home Treatment of Childhood Illnesses Prior to Seeking Formal Care: A Cross-Sectional Study at Different Health Care Levels in Ghana Autoren Rautman LH et al. Sep 2025 J Acquir Immune Defic Syndr Trends in Online and In-Person Sex-Seeking Venues among Men who have Sex with Men in Berlin, Germany Autoren Vyas KJ et al. Sep 2025 Front Immunol Effects of sex but not race and geographic origin on vaccine-induced HIV-specific antibody responses Autoren Mbuya W et al. Sep 2025 NAR Genom Bioinform nf-core/detaxizer: a benchmarking study for decontamination from human sequences Autoren Seidel J et al. Sep 2025 Malar J No evidence of molecular markers of piperaquine resistance in southeastern Nigeria Autoren Ikegbunam M et al. Sep 2025 J Virol Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometry Autoren Hammer E et al. Sep 2025 Sci Rep Scalable and cost-effective methods for xenomonitoring of P. falciparum and antimalarial drug resistance validated with laboratory and wild-caught mosquitoes Autoren Anvari D et al. Pagination Previous page ‹‹ Seite 1 Seite 2 Seite 3 Seite 4 Current page 5 Seite 6 Seite 7 Seite 8 Seite 9 Seite 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Next page ››
Oct 2025 Emerg Infect Dis Seoul Virus Infection Acquired at Private Pet Rat Breeding Facility, Germany, 2024 Autoren Baalmann F et al.
Oct 2025 Clin Microbiol Rev Twenty years of human bocavirus research: from an unculturable virus of unclear pathogenicity to a culturable human pathogen and gene therapy vector candidate Autoren Schildgen O et al.
Sep 2025 Adv Sci (Weinh) Cellular Hallmarks From Volume Electron Microscopy Reveal Developmental Progression of Plasmodium Ookinetes Autoren Darif N et al.
Sep 2025 Am J Trop Med Hyg Clinical and Parasitological Characteristics of Plasmodium vivax Malaria in Malaria-Naïve Patients: A Review of Malaria Fever Therapy in Patients with Schizophrenia and Neurosyphilis during the 1950s and 1960s in Vienna, Austria Autoren Wolff S et al.
Sep 2025 Antimicrob Agents Chemother Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant Candida parapsilosis bloodstream infections Autoren Vena A et al.
Sep 2025 Am J Trop Med Hyg IgM, IgG, and IgG Subclass Antibody Responses to Plasmodium falciparum Proteins in Naïve, Malaria-Vaccinated and Semi-Immune Volunteers after Controlled Human Malaria Infection Autoren Gómez-Pérez GP et al.
Sep 2025 Malar J Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridine Autoren Mombo-Ngoma G et al.
Sep 2025 Sci Rep T cell dysregulation reflects disease stage in hepatitis virus and alcohol-related liver disease Autoren Niehaus C et al.
Sep 2025 EMBO Mol Med Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil Autoren Borrmann S et al.
Sep 2025 BMC Cancer Reviewing the lines of therapy-concept in cancer treatment: a survey study among physicians Autoren Falchetto LMM et al.
Sep 2025 JAC Antimicrob Resist The 2025 EQUAL Pneumocystis Score-an ECMM tool to measure QUALity in Pneumocystis pneumonia management Autoren Haensel L et al.
Sep 2025 Med Microbiol Immunol Effect of controlled human Plasmodium falciparum infection on B cell subsets in individuals with different levels of malaria immunity Autoren Requena P et al.
Sep 2025 Infect Dis Poverty An exploratory study to assess the influence of schistosomiasis on the occurrence of dengue virus in Madagascar Autoren Hey JC et al.
Sep 2025 Epidemiol Infect Evidence of very low hepatitis B virus prevalence in children and adolescents in Germany: National cross-sectional study, 2014-2017 Autoren Gillesberg Lassen S et al.
Sep 2025 Nucleic Acids Res MITE: the Minimum Information about a Tailoring Enzyme database for capturing specialized metabolite biosynthesis Autoren Rutz A et al.
Sep 2025 Eur J Health Econ Do we need a health technology assessment approach for non-inferiority specifically? A comment on: clinical equivalence and non-inferiority within health technology assessment by Taylor et al. (2025) Autoren Gladstone BP Vach W
Sep 2025 Proc Natl Acad Sci U S A Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development Autoren Reuber EE et al.
Sep 2025 Front Immunol Helminthic larval stage induces cellular apoptosis via caspase 9-mediated mitochondrial dysfunction Autoren Sternkopf LE et al.
Sep 2025 Trop Med Int Health Home Treatment of Childhood Illnesses Prior to Seeking Formal Care: A Cross-Sectional Study at Different Health Care Levels in Ghana Autoren Rautman LH et al.
Sep 2025 J Acquir Immune Defic Syndr Trends in Online and In-Person Sex-Seeking Venues among Men who have Sex with Men in Berlin, Germany Autoren Vyas KJ et al.
Sep 2025 Front Immunol Effects of sex but not race and geographic origin on vaccine-induced HIV-specific antibody responses Autoren Mbuya W et al.
Sep 2025 NAR Genom Bioinform nf-core/detaxizer: a benchmarking study for decontamination from human sequences Autoren Seidel J et al.
Sep 2025 Malar J No evidence of molecular markers of piperaquine resistance in southeastern Nigeria Autoren Ikegbunam M et al.
Sep 2025 J Virol Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometry Autoren Hammer E et al.
Sep 2025 Sci Rep Scalable and cost-effective methods for xenomonitoring of P. falciparum and antimalarial drug resistance validated with laboratory and wild-caught mosquitoes Autoren Anvari D et al.
